In a B16F10 mouse melanoma model, activated CD8+CD25+ Tregs were found to release exosomes containing IL-10 and TGF-β, which modulate lymphocyte activity and suppress CTLs responses (Xie et al. 2013). This evidence concerns the gene CD8A and melanoma.